Navigation Links
NABP Applies for New .PHARMACY Generic Top-Level Domain to Provide a Secure Destination for Consumers
Date:6/12/2012

MOUNT PROSPECT, Ill., June 12, 2012 /PRNewswire-USNewswire/ -- The National Association of Boards of Pharmacy® (NABP®), with the support of a global coalition of stakeholders, has applied to the Internet Corporation for Assigned Names and Numbers (ICANN) to own and operate the new .PHARMACY generic Top-Level Domain (gTLD). At a time when the vast majority of Web sites selling prescription drugs online are doing so illegally – many of them selling unapproved, substandard, and counterfeit medicine – NABP is seeking to establish the .PHARMACY space as a secure and trustworthy destination where consumers can be sure the medications they buy online are authentic and safe.

NABP has applied for .PHARMACY as a community-based application representing legitimate online pharmacies and prescription drug-related organizations worldwide. By filing this application, NABP and the coalition seek to ensure that the .PHARMACY gTLD is kept out of the hands of a third party that, for commercial reasons, may turn a blind eye toward illegal and/or counterfeit activity within the gTLD. NABP will ensure that only legitimate Web site operators that adhere to pharmacy laws in the jurisdictions in which they are based and to which they sell medicine will be able to register domain names in .PHARMACY. The ultimate benefactors of this new gTLD will be the health care community and patients worldwide, who will be assured that all pharmacy sites ending in the .PHARMACY gTLD are safe and legitimate.

"The .PHARMACY registry will help us to further protect patients who choose to purchase medications online," states NABP President Michael A. Burleson, RPh. "We will do this by vetting all registrants prior to acceptance so as to ensure that they meet all applicable regulatory standards, including pharmacy licensure, drug authenticity, and valid prescription requirements. NABP is uniquely positioned to accomplish this due to its long history of protecting patients from illegal pharmacies through its VIPPS® (Verified Internet Pharmacy Practice Sites) accreditation program, which has been accrediting online pharmacies since 1999. Additionally, through its Internet Drug Outlet Identification program, NABP has reviewed more than 9,800 Web sites selling prescription drugs to determine if they are operating legitimately. A list of the 'Not Recommended' sites, as well as a list of VIPPS pharmacies, is available for consumers to review and make an educated choice about where they can safely purchase their medications."

As of June 1, 2012, NABP had reviewed 9,837 Internet drug outlets selling prescription medications and found 9,509 Web sites – 97% of the total number of sites reviewed – to be out of compliance with pharmacy laws and practice standards established in the US to protect the public health. Of these 9,509 Web sites identified as Not Recommended, nearly half offer foreign or non-FDA-approved drugs, and many of these distribute dangerous counterfeits to unsuspecting consumers.

NABP, with its coalition of stakeholders, will launch a public awareness campaign leveraging its AWARxE consumer protection program, to educate consumers about the dangers of buying medicine from unknown sources over the Internet and to help build their trust in .PHARMACY sites.

As stated, NABP has applied as a representative of the global pharmacy community, which includes independent community pharmacies, chain drug stores, Internet pharmacies, schools and colleges of pharmacy, patient advocacy groups, pharmaceutical manufacturers, and wholesale distributors of prescription medications. Among the coalition of stakeholders behind this initiative are the Alliance for Safe Online Pharmacies, Eli Lilly and Company, European Alliance for Access to Safe Medicines, Gilead Sciences, Inc, International Pharmaceutical Federation, Janssen Pharmaceuticals, Inc, Merck/MSD, National Association of Pharmacy Regulatory Authorities, and the state boards of pharmacy.

For more information about NABP and its consumer protection programs, visit the NABP Web site at http://www.nabp.net/programs/consumer-protection/buying-medicine-online/.

Established in 1904, NABP is the independent, international, and impartial Association that assists its 54 member state boards of pharmacy and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health.


'/>"/>
SOURCE National Association of Boards of Pharmacy
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
2. Tris Pharma Announces Approval of First-Ever Generic to Delsym® Dextromethorphan Polistirex Extended-Release Suspension
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Mylan Launches Generic Version of Lipitor®
5. Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex®
6. Sihuans First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration
7. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
8. Mylan Launches Generic Version of Viramune® Tablets
9. Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan.
10. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
11. Mylan Launches Generic Version of Plavix® Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... May 24, 2016 Niederländische ... gebracht, die es Ärzten erlaubt, ihre Expertise weltweit ... MDLinking kombiniert Live Streaming mit einer Instant-Messaging-Funktion und ... kommunizieren. Mediziner in Europa, Afrika, Asien und den ... für die Plattform registriert. Information und ...
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
(Date:5/24/2016)... 2016  NxStage Medical, Inc. (Nasdaq: NXTM ... renal care, today announced that Jeffrey H. Burbank ... following schedule of investor conferences. Where applicable, a webcast ... http://ir.nxstage.com/ .   ... NY           Friday, June 10, 2016 1:30 p.m. ET ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... 27, 2016 , ... With a team of certified experts, ... Aside from its GMP accreditation, Validation Center is also a registered authority of ... and staff. , Validation Center is ISO17025 accredited and only offers its clients ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... An April ... American families. , The 550 employees of Sun Health Senior Living (SHSL) ... Aetna that reduces their doctor and prescription copays for the year, while holding the ...
(Date:5/26/2016)... ... ... The Lung Institute has partnered with the Gulfcoast North Area ... at their clinic in downtown Tampa. The class is complimentary for the public. Register ... a free downloadable 4 Week Smoking Cessation Guide for those who are ...
Breaking Medicine News(10 mins):